• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

堪萨斯城心肌病问卷简版的开发与验证

Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire.

作者信息

Spertus John A, Jones Philip G

出版信息

Circ Cardiovasc Qual Outcomes. 2015 Sep;8(5):469-76. doi: 10.1161/CIRCOUTCOMES.115.001958.

DOI:10.1161/CIRCOUTCOMES.115.001958
PMID:26307129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4885562/
Abstract

BACKGROUND

There is a growing demand to collect patients' experiences of their health status (their symptoms, function, and quality of life) in clinical trials, quality assessment initiatives, and in routine clinical care. In heart failure, the 23-item, disease-specific Kansas City Cardiomyopathy Questionnaire (KCCQ) has been shown to be valid, reliable, sensitive to clinical change, and prognostic of both clinical events and costs. However, its use has been limited, in part, by its length. We sought to develop a shortened version of the instrument that maintains the psychometric properties of the full KCCQ.

METHODS AND RESULTS

Using data from 3 clinical studies incorporating 4168 patients, we derived and validated a 12-item KCCQ, the KCCQ-12, to capture symptom frequency, physical and social limitations, and quality of life impairment as a result of heart failure, as well as an overall summary score. The KCCQ-12 scores had high correlations with the original scales (>0.93 for all scales in all clinical settings), high test–retest reliability (>0.76 for all domains), high responsiveness (16–31 point improvements after discharge from hospitalization; standardized response mean =0.61–1.12), and comparable prognostic significance and interpretation of clinically important differences as compared with the full KCCQ.

CONCLUSIONS

The KCCQ-12 is a shorter version of the original 23-item instrument that should be more feasible to implement while preserving the psychometric properties of the full instrument.

摘要

背景

在临床试验、质量评估项目以及日常临床护理中,收集患者健康状况(症状、功能和生活质量)体验的需求日益增长。在心力衰竭领域,23项特定疾病的堪萨斯城心肌病问卷(KCCQ)已被证明是有效的、可靠的,对临床变化敏感,并且对临床事件和成本具有预后价值。然而,其使用在一定程度上受到篇幅的限制。我们试图开发一个缩短版的该工具,同时保持完整KCCQ的心理测量特性。

方法与结果

利用来自3项纳入4168例患者的临床研究的数据,我们推导并验证了一个12项的KCCQ,即KCCQ - 12,以获取因心力衰竭导致的症状频率、身体和社会限制以及生活质量损害情况,以及一个总体汇总分数。KCCQ - 12评分与原始量表具有高度相关性(在所有临床环境中所有量表的相关性均>0.93),具有较高的重测信度(所有领域>0.76),具有较高的反应性(出院后改善16 - 31分;标准化反应均值 = 0.61 - 1.12),并且与完整的KCCQ相比,在临床重要差异的预后意义和解释方面具有可比性。

结论

KCCQ - 12是原始23项工具的缩短版,在保留完整工具心理测量特性的同时,实施起来应该更可行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d1/4885562/8cd73ea806ef/hcq-8-469-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d1/4885562/8cd73ea806ef/hcq-8-469-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d1/4885562/8cd73ea806ef/hcq-8-469-g001.jpg

相似文献

1
Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire.堪萨斯城心肌病问卷简版的开发与验证
Circ Cardiovasc Qual Outcomes. 2015 Sep;8(5):469-76. doi: 10.1161/CIRCOUTCOMES.115.001958.
2
Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure.日本慢性心力衰竭患者使用日本版堪萨斯心肌病问卷的心理测量特性。
Health Qual Life Outcomes. 2020 Jul 17;18(1):236. doi: 10.1186/s12955-020-01483-0.
3
The utility of a specific measure for heart transplant patients: reliability and validity of the Kansas City Cardiomyopathy Questionnaire.一种针对心脏移植患者的特定测量方法的效用:堪萨斯城心肌病问卷的信度和效度
Transplantation. 2008 Sep 27;86(6):804-10. doi: 10.1097/TP.0b013e318183eda4.
4
Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure.心力衰竭患者中堪萨斯城心肌病问卷的心理测量评估:男性与女性。
Circ Heart Fail. 2021 Sep;14(9):e008284. doi: 10.1161/CIRCHEARTFAILURE.120.008284. Epub 2021 Sep 1.
5
Psychometric properties of the Kansas City Cardiomyopathy Questionnaire (KCCQ).堪萨斯城心肌病问卷(KCCQ)的心理测量特性。
Eur J Cardiovasc Nurs. 2012 Jun;11(2):197-206. doi: 10.1177/1474515111435605. Epub 2012 Mar 28.
6
Psychometric Properties of the Kansas City Cardiomyopathy Questionnaire in a Surgical Population of Patients With Aortic Valve Stenosis.堪萨斯城心肌病问卷在主动脉瓣狭窄手术患者人群中的心理测量特性。
Am J Cardiol. 2023 Dec 15;209:165-172. doi: 10.1016/j.amjcard.2023.09.068. Epub 2023 Oct 28.
7
Reliability and Validity of Kansas City Cardiomyopathy Questionnaire in Arabic Patients with Chronic Heart Failure.阿拉伯语慢性心力衰竭患者 Kansas 心肌病问卷的信度和效度。
Medicina (Kaunas). 2023 Oct 28;59(11):1910. doi: 10.3390/medicina59111910.
8
The Kansas City Cardiomyopathy Questionnaire: Italian translation and validation.堪萨斯城心肌病问卷:意大利语翻译与验证
Ital Heart J. 2003 Sep;4(9):620-6.
9
Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction.堪萨斯城心肌病问卷在射血分数保留和降低的心衰患者中的可比表现。
Circ Heart Fail. 2013 Nov;6(6):1139-46. doi: 10.1161/CIRCHEARTFAILURE.113.000359. Epub 2013 Oct 15.
10
Psychometric properties of a Swedish version of the Kansas City Cardiomyopathy Questionnaire in a Chronic Heart Failure population.堪萨斯城心肌病问卷瑞典语版本在慢性心力衰竭人群中的心理测量学特性。
Eur J Cardiovasc Nurs. 2008 Sep;7(3):214-21. doi: 10.1016/j.ejcnurse.2007.08.005. Epub 2007 Dec 3.

引用本文的文献

1
Erratum: Using Implementation Science to Evaluate the Implementation of Patient-Reported Outcome Measures (PROMs) in a Clinical Heart Failure Care Setting.勘误:运用实施科学评估临床心力衰竭护理环境中患者报告结局测量指标(PROMs)的实施情况。
CJC Open. 2025 Jun 13;7(8):1017-1026. doi: 10.1016/j.cjco.2025.06.007. eCollection 2025 Aug.
2
Strain-derived myocardial work indices in adult cancer survivors: results from an observational study and comparison with available reference ranges.成年癌症幸存者的应变衍生心肌工作指数:一项观察性研究的结果及与现有参考范围的比较
Cardiooncology. 2025 Aug 30;11(1):78. doi: 10.1186/s40959-025-00373-y.
3

本文引用的文献

1
Barriers to the use of patient-reported outcomes in clinical care.临床护理中使用患者报告结局的障碍。
Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):2-4. doi: 10.1161/CIRCOUTCOMES.113.000829. Epub 2014 Jan 14.
2
Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction.堪萨斯城心肌病问卷在射血分数保留和降低的心衰患者中的可比表现。
Circ Heart Fail. 2013 Nov;6(6):1139-46. doi: 10.1161/CIRCHEARTFAILURE.113.000359. Epub 2013 Oct 15.
3
Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors.
Health-Related Quality-of-Life Measures in Patients with Heart Failure Cardiogenic Shock Following Axillary Mechanical Circulatory Support.
心力衰竭合并心源性休克患者接受腋动脉机械循环支持后的健康相关生活质量测量
Med Sci (Basel). 2025 Aug 19;13(3):146. doi: 10.3390/medsci13030146.
4
Reliability of a German version of the Kansas City Cardiomyopathy Questionnaire (KCCQ) administered via telephone.通过电话使用的德语版堪萨斯城心肌病问卷(KCCQ)的可靠性。
Sci Rep. 2025 Aug 4;15(1):28444. doi: 10.1038/s41598-025-14179-6.
5
Effect of a digital health intervention on outpatients with heart failure: a randomized, controlled trial.数字健康干预对心力衰竭门诊患者的影响:一项随机对照试验。
Eur Heart J Digit Health. 2025 Jun 10;6(4):749-762. doi: 10.1093/ehjdh/ztaf063. eCollection 2025 Jul.
6
Noninvasive Screening for Elevated LVEDP and Health Status in Outpatients at Risk for Heart Failure.门诊心力衰竭高危患者左心室舒张末期压力升高及健康状况的无创筛查
JACC Adv. 2025 Jul 18;4(8):102002. doi: 10.1016/j.jacadv.2025.102002.
7
Prevalence of Autonomic Dysfunction and Correlation with Markers of Disease Severity in Cardiac Amyloidosis.心脏淀粉样变性中自主神经功能障碍的患病率及其与疾病严重程度标志物的相关性
J Clin Med. 2025 Jul 2;14(13):4682. doi: 10.3390/jcm14134682.
8
Cardiovascular-kidney-metabolic overlaps, clinical outcomes, and quality of life in patients with acute heart failure.急性心力衰竭患者的心血管-肾脏-代谢重叠、临床结局及生活质量
J Nutr Health Aging. 2025 Aug;29(8):100613. doi: 10.1016/j.jnha.2025.100613. Epub 2025 Jun 23.
9
Predictors of disease burden in patients with untreated transthyretin amyloid cardiomyopathy and their caregivers: a analysis of an international survey.未经治疗的转甲状腺素蛋白淀粉样心肌病患者及其照料者疾病负担的预测因素:一项国际调查分析
Front Cardiovasc Med. 2025 Jun 9;12:1595797. doi: 10.3389/fcvm.2025.1595797. eCollection 2025.
10
Does race influence health-related quality of life outcomes in older patients who undergo advanced cardiac surgical therapies?种族会影响接受晚期心脏外科治疗的老年患者与健康相关的生活质量结果吗?
JHLT Open. 2025 May 13;9:100286. doi: 10.1016/j.jhlto.2025.100286. eCollection 2025 Aug.
疾病管理:植入式除颤器、再同步装置和血流动力学监测器的心力衰竭患者的远程监测。
Europace. 2013 Jun;15 Suppl 1:i40-i46. doi: 10.1093/europace/eut105.
4
Assessing health-related quality of life in patients with heart failure: a systematic, standardized comparison of available measures.评估心力衰竭患者与健康相关的生活质量:对现有测量方法的系统、标准化比较。
Heart Fail Rev. 2014 May;19(3):359-67. doi: 10.1007/s10741-013-9394-7.
5
Adding serial N-terminal pro brain natriuretic peptide measurements to optimal clinical management in outpatients with systolic heart failure: a multicentre randomized clinical trial (NorthStar monitoring study).在门诊射血分数降低性心力衰竭患者的优化临床管理中添加连续 N 端脑利钠肽前体测量:一项多中心随机临床试验(NorthStar 监测研究)。
Eur J Heart Fail. 2013 Jul;15(7):818-27. doi: 10.1093/eurjhf/hft037. Epub 2013 Mar 18.
6
Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the CardioMEMS Champion Heart Failure Monitoring System.2011 年食品和药物管理局循环系统设备顾问委员会会议上关于 CardioMEMS Champion 心力衰竭监测系统的概述。
J Am Coll Cardiol. 2013 Apr 16;61(15):1571-6. doi: 10.1016/j.jacc.2012.08.1035. Epub 2013 Jan 23.
7
Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis.使用堪萨斯城心肌病问卷监测主动脉瓣狭窄患者的健康状况。
Circ Heart Fail. 2013 Jan;6(1):61-7. doi: 10.1161/CIRCHEARTFAILURE.112.970053. Epub 2012 Dec 10.
8
Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction.应用氨基末端脑利钠肽前体指导慢性左心室收缩功能障碍患者的门诊治疗。
J Am Coll Cardiol. 2011 Oct 25;58(18):1881-9. doi: 10.1016/j.jacc.2011.03.072.
9
Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.无线肺动脉血流动力学监测在慢性心力衰竭中的应用:一项随机对照试验。
Lancet. 2011 Feb 19;377(9766):658-66. doi: 10.1016/S0140-6736(11)60101-3.
10
Patient health status and costs in heart failure: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS).心力衰竭患者的健康状况与成本:依普利酮急性心肌梗死后心力衰竭疗效和生存研究(EPHESUS)的见解
Circulation. 2009 Jan 27;119(3):398-407. doi: 10.1161/CIRCULATIONAHA.108.820472. Epub 2009 Jan 12.